MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-17-2026
NanoViricides P/B Ratio 2011-2026 | NNVC
Annual P/B Ratio NanoViricides
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.85 | 1.5 | 0.946 | 0.845 | 1.08 | 1.59 | 1.56 | 1.4 | 4.38 | 4.38 | 2.67 | 7.4 | 18.9 | 5.19 | 16 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 18.9 | 0.845 | 4.71 |
P/B Ratio of other stocks in the Biotechnology industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
1.66 | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M |  Germany |
 |
Happiness Biotech Group Limited
HAPP
|
0.115 | - | 1.35 % | $ 17.8 M |  China |
 |
AgeX Therapeutics
AGE
|
7.09 | - | -10.17 % | $ 12.2 K |  USA |
 |
Coherus BioSciences
CHRS
|
3.71 | $ 1.72 | 4.57 % | $ 201 M | USA |
 |
I-Mab
IMAB
|
1.12 | - | - | $ 866 M | China |
 |
Celldex Therapeutics
CLDX
|
3.87 | $ 31.9 | 3.39 % | $ 2.12 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
596 | - | 2.54 % | $ 160 B | France |
 |
BioNTech SE
BNTX
|
1.15 | $ 94.08 | 1.98 % | $ 22.7 B | Germany |
 |
AstraZeneca PLC
AZN
|
2.82 | - | - | $ 96.9 B |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
0.036 | - | - | $ 269 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
7.43 | - | 0.74 % | $ 768 M |  Israel |
 |
Compugen Ltd.
CGEN
|
1.25 | $ 2.68 | 0.75 % | $ 250 M | Israel |
 |
Abcam plc
ABCM
|
6.8 | - | - | $ 4.9 B | Britain |
 |
Galera Therapeutics
GRTX
|
-0.0532 | - | -32.59 % | $ 7.61 M | USA |
 |
Midatech Pharma plc
MTP
|
173 | - | -18.52 % | $ 27.3 M | Britain |
|
Enlivex Therapeutics Ltd.
ENLV
|
0.0227 | $ 0.75 | 9.37 % | $ 34.3 M | Israel |
 |
Esperion Therapeutics
ESPR
|
-1.86 | $ 3.13 | 0.32 % | $ 651 M | USA |
 |
Eton Pharmaceuticals
ETON
|
21.4 | $ 31.76 | 1.5 % | $ 855 M | USA |
 |
Affimed N.V.
AFMD
|
2.34 | - | -34.95 % | $ 21.5 M | Germany |
|
Forte Biosciences
FBRX
|
5.5 | $ 22.94 | 4.54 % | $ 297 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - |  Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
0.759 | - | - | $ 231 M | USA |
 |
Celyad Oncology SA
CYAD
|
0.539 | - | - | $ 12.5 M |  Belgium |
 |
Berkeley Lights
BLI
|
0.824 | - | -7.31 % | $ 87 M | USA |
 |
Generation Bio Co.
GBIO
|
0.879 | - | - | $ 344 M | USA |
 |
IMV
IMV
|
-1.04 | - | - | $ 13.1 M | Canada |
 |
Akero Therapeutics
AKRO
|
4.34 | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
0.786 | - | 0.23 % | $ 488 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.994 | - | - | $ 7.46 M | Israel |
 |
Grifols, S.A.
GRFS
|
0.525 | $ 8.16 | 1.87 % | $ 5.55 B |  Spain |
 |
Hutchison China MediTech Limited
HCM
|
9.59 | $ 11.93 | 1.53 % | $ 10.2 B | China |
 |
Cyclacel Pharmaceuticals
CYCCP
|
-0.0503 | - | -4.36 % | $ 27 M | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
4.98 | - | - | $ 384 M | Britain |
 |
Heron Therapeutics
HRTX
|
13.8 | $ 0.92 | 3.78 % | $ 153 M | USA |
 |
Gracell Biotechnologies
GRCL
|
1.09 | - | - | $ 3.37 B | China |
 |
Anika Therapeutics
ANIK
|
1.12 | $ 14.69 | -1.36 % | $ 211 M | USA |
 |
Advaxis
ADXS
|
0.113 | - | -9.65 % | $ 45.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
1.12 | - | 5.93 % | $ 314 M | Canada |
 |
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
5.13 | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.458 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
0.492 | - | 1.93 % | $ 17.4 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
0.505 | $ 3.42 | -0.73 % | $ 5.63 M | Israel |
 |
Aptose Biosciences
APTO
|
-0.511 | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
0.248 | - | -39.0 % | $ 4.57 M | USA |
 |
Albireo Pharma
ALBO
|
3.12 | - | -0.23 % | $ 916 M | USA |